logo
How new BookMyForex card with no ATM, cross-currency fees stacks up

How new BookMyForex card with no ATM, cross-currency fees stacks up

Mint19-05-2025

NEW DELHI
:
Currency exchange service provider BookMyForex (BMF), a MakeMyTrip company, has launched a new forex card with two key offerings—zero fee on ATM withdrawal and cross-currency conversion.
International ATM withdrawals with debit, credit, and forex cards levy a ₹150-500 fee per transaction. But the Global Forex Card, a single-currency forex card denominated only in US dollars, doesn't charge this fee.
The BMF card also solves the biggest challenge associated with forex cards—cross-currency conversion. When forex cards are used in a country with a currency different from the one loaded, a cross-currency fee of 2-3.5% is charged.
Also Read: Schengen, US visas: How to crack the application process and ensure that your summer travel plans go ahead smoothly
A forex card loaded in USD used in Sri Lanka will carry forex charges at two points: first, when converting INR to USD while loading the card, and second, when converting USD to Sri Lankan Rupee at the time of payment—the cross-currency conversion fee. The BMF card also saves on this.
This card can be particularly helpful in small countries such as Sri Lanka, Vietnam, Cambodia, Thailand, etc., whose currencies are not supported by even multi-currency forex cards. So far, the use case of forex cards in such countries as a means of payment for international transactions has remained limited, as their currencies are not supported by any forex card available in India.
The BMF Global Forex Card changes that as it can be used in any country without worrying about a cross-currency conversion fee.
Its features
Forex rates offered by BMF are among the cheapest when compared to major banks and other forex marketplaces and are very close to the mid-market rates. As for the various charges, the forex card comes with zero forex mark-up, loading, unloading, and annual fees. There is no issuance fee either. However, a small delivery fee, which varies across different cities, is to be paid.
Also Read: Travel hacks for a luxury Sri Lanka trip for just ₹1.5 lakh
BMF doesn't charge anything to customers and earns only through the merchant discount rate (MDR) charged to merchants, said Sudarshan Motwani, founder and chief executive of the MMT platform.
BMF's flagship offering is its multi-currency forex card that charges a 3.5% cross-currency conversion rate and a ₹100-450 fee on international ATM withdrawals. The newly launched USD-denominated Global Forex Card does not carry both these charges, making it a one-of-a-kind forex card.
Zero ATM withdrawal fee is a useful feature as it's a convenient way to get local currency in cities where cards are not accepted for payments. When a cardholder makes an ATM withdrawal in a foreign country, the conversion rate from USD to the local currency will be as per the bank.
For a limited time, BMF Global Forex Card holders will be rewarded 2% cash back on every forex transaction, capped at a maximum of ₹7,500.
Should you get it?
For international travel, travellers can choose between credit, debit, and forex cards for their digital payments. Debit cards cost the most among these three options as banks charge a steep forex mark-up of 2-4%.
New-age fintech companies such as Niyo and Fi offer zero forex mark-up debit cards in association with banks, but you will need to open a new bank account just to get the zero mark-up feature. These bank accounts need a minimum monthly or quarterly account balance of ₹5,000-10,000, else a monthly ₹150-200 fee is slapped.
Zero mark-up credit cards, such as IDFC FIRST WOW Travel Credit Card, Scapia and RBL World Safari Credit Card, are a better alternative.
The other option is to get a credit card with a high reward rate that can fully or partially offset the forex markup charged on it, reducing the net cost. For instance, HDFC Infinia's forex fee is 2%, whereas its base reward rate is 3.3%, which means the reward rate will not only offset the forex markup but also earn a net 1.3% reward rate.
Also Read: This 20-year-old travelled to three countries for under ₹90,000. Here's how.
The BMF card is a better option than debit cards and can be considered by those who don't use credit cards. Students living abroad can also benefit from the low costs.
'As long as the student remains abroad for their studies, they can use the card without any time restrictions. It can only be loaded in USD as of now. However, it can be used globally wherever Visa is accepted without any conversion charges," said Motwani.
It should be noted that forex cards fall under the Liberalised Remittance Scheme and attract a 20% tax collection at source after ₹10 lakh. This can impact students living abroad as their annual expenses can easily exceed this threshold.
The absence of ATM withdrawal fees is a positive feature of the BMF Global Forex Card, said Sumanta Mandal, founder of Technofino. 'But keep in mind that the bank whose ATM you use might still charge you for using a foreign card. So, the choice of ATM is also very important."
How to get it
You can apply for the card on BMF's mobile application or website. Motwani explained there was a two-step KYC process. 'First, we use OCR (Optical Character Recognition) technology to capture and verify the customer's KYC documents digitally. This is then followed by an in-person KYC at the time of card delivery, ensuring full compliance with regulatory standards."
The card is delivered in about 25 cities.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY
AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY

Business Standard

time24 minutes ago

  • Business Standard

AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY

AstraZeneca Pharma surged 10.03% to Rs 8764.05 after the company's standalone net profit rose 47.54% to Rs 58.25 crore, while revenue from operations rose 25.39% to Rs 480.48 crore in Q4 March 2025 over Q4 March 2024. Profit before tax (PBT) stood at Rs 78.47 crore in Q4 FY25, up 44.35% year-on-year, and up 86.74% quarter-on-quarter. Total expenses rose 22.22% to Rs 412.48 crore in Q4FY25 over Q4FY24. During the quarter, cost of materials consumed stood at Rs 94.25 crore (up 180.34% YoY) while employee benefits expense was at Rs 66.07 crore (up 13.95% YoY). The company's net profit surged 88.82% while net sales rose 9.13% in Q4 March 2025 over Q3 December 2024. For the full year FY25, revenue from operations rose 32.48% to Rs 1,716.29 crore, while net profit fell 28.34% to Rs 115.74 crore. PBT fell 28.78% to Rs 156.36 crore compared to FY24. The company's standalone net cash from operating activities stood at Rs 65.36 crore in FY25, as against Rs 27.87 crore in FY24. Dr. Sanjeev Panchal, country president & managing director of the company, said, "Our company delivered strong growth in Financial Year 2024-25 by launching innovative medicines in India, giving us momentum into 2025 and beyond. We are pleased to share that our company has, for the first time, crossed the INR 1,700 crore mark ($200 million)." The board recommended dividend of Rs 32 per equity share for FY25. AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in four areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Rare Diseases. It operates in over 100 countries.

India to need 1 million AI professionals by 2026, says report amid tech education overhaul
India to need 1 million AI professionals by 2026, says report amid tech education overhaul

Time of India

time28 minutes ago

  • Time of India

India to need 1 million AI professionals by 2026, says report amid tech education overhaul

India is poised to see a massive surge in demand for Artificial Intelligence (AI) professionals, with projections estimating the need for one million skilled individuals by 2026, according to the report India's AI Revolution: A Roadmap to Viksit Bharat, released by the Union Ministry of Electronics & the country aspires to become a USD 23-USD 35 trillion economy by 2047, higher education--particularly in engineering--is undergoing a fundamental transformation to meet the demands of a rapidly evolving job market shaped by AI, automation, and interdisciplinary innovation. Engineering education is at the heart of this shift. According to the All-India Council for Technical Education (AICTE), the number of approved B. Tech seats for the 2024-25 academic year has risen to 14.9 lakh--a nearly 16 per cent increase over four years. This growth is largely driven by a more than 50 per cent rise in seats for Computer Science and allied streams such as AI/ML, Data Science, Cybersecurity, Cloud Computing, and Blockchain--mirroring strong industry demand. India's tech education landscape is increasingly embracing interdisciplinary and industry-integrated learning to nurture a new generation of engineers who can code, create, collaborate, and lead innovation. The transition from STEM (Science, Technology, Engineering, Mathematics) to STEAM, adding Arts to the mix, is gaining ground, blending technical knowledge with design thinking, communication, psychology, law, and business. Recently, Symbiosis International (Deemed University) announced the launch of Symbiosis Artificial Intelligence Institute (SAII), an artificial intelligence (AI)-focused institute. According to the institute, SAII will integrate cutting-edge AI into academic programmes and research. "By embracing AI, we are not just keeping pace with global innovation but also empowering our students to become responsible innovators and problem-solvers who will shape the future. Curriculum at Symbiosis combines strong theoretical foundations with real-world applications from day one, creating a dynamic ecosystem that fosters both technical depth and interdisciplinary breadth. And this reflects in programs offered by our Symbiosis Dubai campus. Both B. Tech and BCA integrate AI in specialisations enforcing learning and development and preparing students for the future," said Amruta Yeravdekar Ruikar, Head of International Admissions & Promotions, Symbiosis International University. The India Skills Report 2024 by Wheebox forecasts that India's AI industry will reach USD 28.8 billion by 2025, with a CAGR of 45 per cent. The report highlights that the AI-skilled workforce has seen a 14-fold increase from 2016 to 2023, making India one of the top five fastest-growing AI talent hubs, alongside Singapore, Finland, Ireland, and Canada. "The surge in demand for AI professionals' stems from rapid technological progress. As AI reshapes productivity, operations, and innovation, preparing a future-ready workforce is imperative. At SRM Institute of Science and Technology, we offer interdisciplinary programs in areas like Medical Engineering, ECE with Data science, Biotechnology (Food Technology) and AI-ML Embedded Systems to bridge emerging domains. Our strong academia-industry partnerships provide students with real-world exposure and global competitiveness," according to Dr. Kathiravan Kannan, Director, SRM Group of Institutions, Ramapuram, Chennai and Tiruchirappalli. This interdisciplinary momentum is now a nationwide trend as institutions are increasingly embedding research-driven curricula, industry mentorship and global exposure into their programs. New focus areas like Extended Reality (XR), ethical AI, data visualization, and digital manufacturing are becoming foundational to modern tech education. According to Dr Yajulu Medury, Vice Chancellor, Mahindra University, "We see a growing need to foster an innovation ecosystem driven by AI, for today's youth by providing experiential learning opportunities such as internships, global immersion programmes, and research initiatives. At Mahindra University, we believe academic excellence is achieved when rigorous foundational knowledge is seamlessly integrated with real-world applications. Our multidisciplinary approach empowers students to understand the technical concepts of AI while also cultivating critical problem-solving abilities, adaptability, ethics and emotional intelligence."

Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets
Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets

Business Standard

time32 minutes ago

  • Business Standard

Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Rifaximin Tablets, 550 mg (USRLD: Xifaxan Tablets, 550 mg). Rifaximin tablets are indicated for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Rifaximin tablets will be produced at the Group's manufacturing site at SEZ II, Ahmedabad. Rifaximin tablets had annual sales of USD $2672.9 mn in the United States (IQVIA MAT March 2025).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store